<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(1)</volume><submitter>Adua E</submitter><funding>School of Science, Edith Cowan University</funding><pubmed_abstract>Plasma N-glycan profiles have been shown to be defective in type II diabetes Mellitus (T2DM) and holds a promise to discovering biomarkers. The study comprised 232 T2DM patients and 219 healthy individuals. N-glycans were analysed by high-performance liquid chromatography. The multivariate integrative framework, DIABLO was employed for the statistical analysis. N-glycan groups (GPs 34, 32, 26, 31, 36 and 30) were significantly expressed in T2DM in component 1 and GPs 38 and 20 were related to T2DM in component 2. Four clusters were observed based on the correlation of the expressive signatures of the 39 N-glycans across T2DM and controls. Cluster A, B, C and D had 16, 16, 4 and 3 N-glycans respectively, of which 11, 8, 1 and 1 were found to express differently between controls and T2DM in </pubmed_abstract><journal>Scientific reports</journal><pagination>10974</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9243128</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Multi-block data integration analysis for identifying and validating targeted N-glycans as biomarkers for type II diabetes mellitus.</pubmed_title><pmcid>PMC9243128</pmcid><pubmed_authors>Peprah-Yamoah E</pubmed_authors><pubmed_authors>Acheampong E</pubmed_authors><pubmed_authors>Awuah-Mensah KA</pubmed_authors><pubmed_authors>Adua E</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Anto EO</pubmed_authors><pubmed_authors>Afrifa-Yamoah E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Multi-block data integration analysis for identifying and validating targeted N-glycans as biomarkers for type II diabetes mellitus.</name><description>Plasma N-glycan profiles have been shown to be defective in type II diabetes Mellitus (T2DM) and holds a promise to discovering biomarkers. The study comprised 232 T2DM patients and 219 healthy individuals. N-glycans were analysed by high-performance liquid chromatography. The multivariate integrative framework, DIABLO was employed for the statistical analysis. N-glycan groups (GPs 34, 32, 26, 31, 36 and 30) were significantly expressed in T2DM in component 1 and GPs 38 and 20 were related to T2DM in component 2. Four clusters were observed based on the correlation of the expressive signatures of the 39 N-glycans across T2DM and controls. Cluster A, B, C and D had 16, 16, 4 and 3 N-glycans respectively, of which 11, 8, 1 and 1 were found to express differently between controls and T2DM in </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2026-06-03T08:21:19.326Z</modification><creation>2022-07-08T09:05:55.875Z</creation></dates><accession>S-EPMC9243128</accession><cross_references><pubmed>35768493</pubmed><doi>10.1038/s41598-022-15172-z</doi></cross_references></HashMap>